Fact.MR – A Market Research and Competitive Intelligence Provider: Sales in the global plasma fractionation market are slated to increase at a 7% CAGR, reaching US$ 38 Bn by 2031, as per Fact.MR.
Intravenous Immunoglobulins to Account for 40% Sales in Plasma Fractionation Market
In a recent market survey, Fact.MR analysis the current plasma fractionation market scenarios and highlights noteworthy developments in market segments in terms of product, application, and end users. The report highlights vital factors impacting sales of plasma fractionation such as drivers, trends, opportunities, and restraints to help readers understand the market dynamics.
Fact.MR – A Market Research and Competitive Intelligence Provider: Sales in the global plasma fractionation market are slated to increase at a 7% CAGR, reaching US$ 38 Bn by 2031, as per Fact.MR. Rising incidence of respiratory disorders in the geriatric population is propelling the establishment of new plasma collection centers, which in turn is fueling the market.
Advent of ailments caused by stress, infections, immunological disorders, and congenital deficiencies is leading to the adoption of plasma therapy for treatment. The onset of the novel COVID-19 outbreak has resulted in the prevalence of respiratory diseases that infect the lungs.
Patients with high blood pressure and diabetes face more difficulties when affected by respiratory disorders. To treat such ailments, plasma fractionation is actively being applied. In addition to this, increasing applications of immunoglobulins derived from plasma to treat such ailments are expected to drive the market in the forthcoming years.
Want A Detailed Understanding of Market Functioning? Request for a Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=4806
Increasing investments in therapies such as ceruloplasmin, Plasmin, and IgA for the treatment of various autoimmune and inflammatory diseases are expected to bode well for the market. Besides this, growing investments in innovation and technological advancements for efficient and cost-effective procedures to improve protein fractioning will continue boosting the market over the forecast period.
As per Fact.MR, demand in the U.S. for plasma fractionation will continue to increase over the forecast period. Growing prevalence of autoimmune diseases and haemophilia, along with the presence of leading market players and a robust healthcare industry will continue propelling sales in the market.
"Increasing adoption of plasma fractionation in the development of biotherapeutic drugs, coupled with the ongoing advancements in isolation techniques will continue fuelling the growth in the market through 2031," says a Fact.MR analyst.
Key Takeaways:
- Demand in the neurological segment is expected to surge at 7.2% CAGR, accounting for 2/5th of the total market share.
- In terms of end users, the hospital segment is projected to account for nearly 35% of the total demand.
- Based on product type, the intravenous immunoglobulins segment is anticipated to command 2/5th of the total market share.
- The U.S. is anticipated to lead the North America market, with sales growing at a 6.6% CAGR over the forecast period.
- China is forecast to emerge as a lucrative pocket in the East Asia Market, with sales in Asia Pacific projected to increase at a robust 8% CAGR.
Growth Drivers:
- Rising awareness regarding regular check-ups for early diagnosis of neurological diseases is expected to fuel sales.
- Growing prevalence of chronic and infectious diseases in emerging economies is driving investments in the healthcare sectors. This is expected to boost sales in the forthcoming years.
Need more information about Report Methodology of Plasma Fractionation Market? Ask here
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806
Competitive Landscape
Leading players operating in the global plasma fractionation market are investing in facility expansions to gain a competitive edge in the market via mergers, acquisitions, and collaborations. In addition to this, players are investing in research and development to diversify their product portfolios.
For instance, in November 2021, Biotest AG received the operating license for its 7th plasma collection center in the Czech Republic from the country's national public health authority SUKL. The new centre has 15 donor beds and will be open 6 days a week for 12 hours a day.
Key Players in the Plasma Fractionation Market Include:
- CSL Behring, Shire Plc.
- Sanquin
- Biotest AG
- GRIFOLS SA
- Baxter International Inc.
- Kedrion
- Octapharma USA Inc.
- Others
More Valuable Insights on Plasma Fractionation Market
Fact.MR provides an unbiased analysis of the plasma fractionation market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global plasma fractionation market with a detailed segmentation on the basis of:
Product:
- Immunoglobulins for Plasma Fractionation
- Intravenous Immunoglobulins
- Subcutaneous Immunoglobulins
- Coagulation Factor Concentrates for Plasma Fractionation
- Factor VIII
- Factor IXF
- Factor XIII
- Prothrombin Complex Concentrate
- Von Willebrand Factor (VWF)
- Fibrinogen Concentrates
- Albumin for Plasma Fractionation
- Protease Inhibitors for Plasma Fractionation
Application:
- Plasma Fractionation for Neurology
- Plasma Fractionation for Immunology
- Plasma Fractionation for Haematology
- Plasma Fractionation for Critical Care
- Plasma Fractionation for Pulmonary Applications
- Plasma Fractionation for Other Applications
End User:
- Plasma Fractionation for Hospitals & Clinics
- Plasma Fractionation for Clinical Research Laboratories
- Plasma Fractionation for Academic Institutions
Regions:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- MEA
Key Questions Covered in Plasma Fractionation Market Report
- The report offers insight into the plasma fractionation market demand outlook for 2021-2031.
- The market study also highlights projected sales growth for plasma fractionation market between 2021 and 2031.
- Plasma fractionation market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
- Plasma fractionation market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.
Explore Fact.MR’s Coverage on the Healthcare Domain –
Plasma-derived Protein Therapies Market Analysis - By restoring missing or inadequate proteins, plasma-derived therapies enable people with chronic and life-threatening disorders to live more productive and healthy lives. During the projected period, the plasma-derived protein therapies market is expected to rise due to increased immunoglobulin usage in developed nations and significant demand for albumin in Asia Pacific. The market for plasma-derived protein therapeutics is expected to grow as a result of increased focus and investment in innovation. Several proteins' purification and plasma fractionation capacity will be increased as a result of the investment. As a result, the market for plasma-derived protein therapies is expected to develop significantly.
Immunoglobulins Market Research - The global immunoglobulins market is expected to grow rapidly, owing to an increase in the prevalence of autoimmune illnesses. Immunoglobulins are being used more frequently for off-label indications, and this trend is expected to continue. Guillain-Barre Syndrome, multifocal motor neuropathy, dermatomyositis, and stiff person syndrome are all common off-label indications treated with intravenous and subcutaneous immunoglobulins. The continuing new coronavirus pandemic will also benefit the global immunoglobulins market, as healthcare practitioners are conducting extensive research into the use of immunoglobulins in COVID-19 treatment.
Plasmapheresis Market Forecast - The rising prevalence of autoimmune illnesses has resulted in an increase in demand for plasmapheresis around the world. The growing need for extracorporeal therapy is likely to positively impact the global autoimmune disorders market's growth. Type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis, and lupus are just a few of the autoimmune illnesses that are driving growing demand for plasmapheresis. Manufacturers in the healthcare industry are rapidly incorporating numerous technological breakthroughs and new features in plasmapheresis instruments, such as apheresis machines, in order to provide improved equipment for performing plasmapheresis around the world.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR